Our analysis of microarray data uncovered an elevated MIG6 expression when AXL was overexpressed in CL1–0 cells, prompting an investigation into the interplay among AXL, MIG6 and EGFR in NSCLC. The gene discussed is AXL; the disease is non-small cell lung carcinoma.